• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MECP2通过抑制miR-338介导的抗增殖作用促进胃癌细胞生长。

MECP2 promotes the growth of gastric cancer cells by suppressing miR-338-mediated antiproliferative effect.

作者信息

Tong Dongdong, Zhao Lingyu, He Kang, Sun Hongfei, Cai Donghui, Ni Lei, Sun Ruifang, Chang Su'e, Song Tusheng, Huang Chen

机构信息

Department of Cell Biology and Genetics, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Shaanxi, P. R. China.

Key Laboratory of Environment and Genes Related to Diseases, Xi'an Jiaotong University, Ministry of Education of China, Shaanxi, P. R. China.

出版信息

Oncotarget. 2016 Jun 7;7(23):34845-59. doi: 10.18632/oncotarget.9197.

DOI:10.18632/oncotarget.9197
PMID:27166996
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5085194/
Abstract

The methyl-CpG-binding protein 2 (MECP2), a transcriptional suppressor, is involved in gene regulation by binding to methylated promoters. We found that MECP2 is overexpressed in gastric cancer (GC), and that Mecp2 knockdown affects the growth of GC cells both in vitro and in vivo. MECP2 can directly bind to the methylated-CpG island of miR-338 promoter and suppress the expression of two mature microRNAs, namely, miR-338-3p and miR-338-5p. Furthermore, miR-338-5p can suppress GC cell growth by targeting BMI1 (B lymphoma Mo-MLV insertion region 1 homolog). We additionally found that decreased miR-338-5p expression in GC tissues, relative to normal tissues, was significantly negatively correlated with increased BMI1 expression. Silencing MECP2 can indirectly lead to reduced expression of P-REX2, which has been identified as the miR-338-3p target, as well as BMI1 and increasing expression of P16 or P21 both in vitro and in vivo. Altogether, our results indicate that MECP2 promote the proliferation of GC cells via miR-338 (miR-338-3p and miR-338-5p)-mediated antitumor and gene regulatory effect.

摘要

甲基化CpG结合蛋白2(MECP2)是一种转录抑制因子,通过与甲基化启动子结合参与基因调控。我们发现MECP2在胃癌(GC)中过表达,并且敲低Mecp2会影响GC细胞在体外和体内的生长。MECP2可直接结合miR - 338启动子的甲基化CpG岛,并抑制两种成熟微RNA即miR - 338 - 3p和miR - 338 - 5p的表达。此外,miR - 338 - 5p可通过靶向BMI1(B淋巴瘤Mo - MLV插入区域1同源物)来抑制GC细胞生长。我们还发现,相对于正常组织,GC组织中miR - 338 - 5p表达降低与BMI1表达增加显著负相关。沉默MECP2可间接导致P - REX2(已被确定为miR - 338 - 3p的靶点)以及BMI1的表达降低,并在体外和体内增加P16或P21的表达。总之,我们的结果表明,MECP2通过miR - 338(miR - 338 - 3p和miR - 338 - 5p)介导的抗肿瘤和基因调控作用促进GC细胞增殖。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b46/5085194/0392eb389fcc/oncotarget-07-34845-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b46/5085194/608116ab8825/oncotarget-07-34845-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b46/5085194/5eadd715a77f/oncotarget-07-34845-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b46/5085194/de40feb5f175/oncotarget-07-34845-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b46/5085194/fef044d231dc/oncotarget-07-34845-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b46/5085194/75952d23e629/oncotarget-07-34845-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b46/5085194/0392eb389fcc/oncotarget-07-34845-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b46/5085194/608116ab8825/oncotarget-07-34845-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b46/5085194/5eadd715a77f/oncotarget-07-34845-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b46/5085194/de40feb5f175/oncotarget-07-34845-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b46/5085194/fef044d231dc/oncotarget-07-34845-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b46/5085194/75952d23e629/oncotarget-07-34845-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b46/5085194/0392eb389fcc/oncotarget-07-34845-g006.jpg

相似文献

1
MECP2 promotes the growth of gastric cancer cells by suppressing miR-338-mediated antiproliferative effect.MECP2通过抑制miR-338介导的抗增殖作用促进胃癌细胞生长。
Oncotarget. 2016 Jun 7;7(23):34845-59. doi: 10.18632/oncotarget.9197.
2
MeCP2 regulated glycogenes contribute to proliferation and apoptosis of gastric cancer cells.甲基化CpG结合蛋白2调控的糖原基因有助于胃癌细胞的增殖和凋亡。
Glycobiology. 2017 Apr 1;27(4):306-317. doi: 10.1093/glycob/cwx006.
3
miR-188-5p emerges as an oncomiRNA to promote gastric cancer cell proliferation and migration via upregulation of SALL4.miR-188-5p 作为一种致癌 miRNA,通过上调 SALL4 促进胃癌细胞增殖和迁移。
J Cell Biochem. 2019 Sep;120(9):15027-15037. doi: 10.1002/jcb.28764. Epub 2019 Apr 22.
4
MeCP2 Promotes Gastric Cancer Progression Through Regulating FOXF1/Wnt5a/β-Catenin and MYOD1/Caspase-3 Signaling Pathways.MeCP2 通过调控 FOXF1/Wnt5a/β-catenin 和 MYOD1/Caspase-3 信号通路促进胃癌进展。
EBioMedicine. 2017 Feb;16:87-100. doi: 10.1016/j.ebiom.2017.01.021. Epub 2017 Jan 17.
5
miR-212 is downregulated and suppresses methyl-CpG-binding protein MeCP2 in human gastric cancer.miR-212 在人胃癌中下调并抑制甲基化-CpG 结合蛋白 MeCP2。
Int J Cancer. 2010 Sep 1;127(5):1106-14. doi: 10.1002/ijc.25126.
6
miR-19a/b and MeCP2 repress reciprocally to regulate multidrug resistance in gastric cancer cells.miR-19a/b 和 MeCP2 相互抑制调节胃癌多药耐药。
Int J Mol Med. 2018 Jul;42(1):228-236. doi: 10.3892/ijmm.2018.3581. Epub 2018 Mar 22.
7
LINC00319 acts as a sponge to accelerate tumor growth and metastasis in gastric cancer by upregulating .LINC00319 通过上调 充当胃癌中肿瘤生长和转移的“海绵体”。
Am J Physiol Gastrointest Liver Physiol. 2020 Jan 1;318(1):G10-G22. doi: 10.1152/ajpgi.00405.2018. Epub 2019 Aug 21.
8
Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.癌细胞中与甲基化诱导的基因沉默相关的染色质结构改变:可及性、甲基化、MeCP2结合与乙酰化的相关性
Nucleic Acids Res. 2001 Nov 15;29(22):4598-606. doi: 10.1093/nar/29.22.4598.
9
MicroRNA-22 regulates smooth muscle cell differentiation from stem cells by targeting methyl CpG-binding protein 2.微小RNA-22通过靶向甲基化CpG结合蛋白2调控干细胞向平滑肌细胞的分化。
Arterioscler Thromb Vasc Biol. 2015 Apr;35(4):918-29. doi: 10.1161/ATVBAHA.114.305212. Epub 2015 Feb 26.
10
Long noncoding RNA NEAT1 promotes the growth of gastric cancer cells by regulating miR-497-5p/PIK3R1 axis.长链非编码 RNA NEAT1 通过调控 miR-497-5p/PIK3R1 轴促进胃癌细胞的生长。
Eur Rev Med Pharmacol Sci. 2019 Aug;23(16):6914-6926. doi: 10.26355/eurrev_201908_18731.

引用本文的文献

1
Updating the therapeutic role of ginsenosides in breast cancer: a bibliometrics study to an in-depth review.更新人参皂苷在乳腺癌治疗中的作用:从文献计量学研究到深入综述
Front Pharmacol. 2023 Sep 25;14:1226629. doi: 10.3389/fphar.2023.1226629. eCollection 2023.
2
The Epigenetic Reader Methyl-CpG-Binding Protein 2 (MeCP2) Is an Emerging Oncogene in Cancer Biology.表观遗传阅读蛋白甲基化CpG结合蛋白2(MeCP2)是癌症生物学中一种新出现的癌基因。
Cancers (Basel). 2023 May 9;15(10):2683. doi: 10.3390/cancers15102683.
3
Long non-coding RNA LINC00240 promotes gastric cancer progression via modulating miR-338-5p/METTL3 axis.

本文引用的文献

1
MicroRNA-203 inhibits cellular proliferation and invasion by targeting Bmi1 in non-small cell lung cancer.微小RNA-203通过靶向Bmi1抑制非小细胞肺癌的细胞增殖和侵袭。
Oncol Lett. 2015 Jun;9(6):2639-2646. doi: 10.3892/ol.2015.3080. Epub 2015 Mar 27.
2
DNMT1 activates the canonical Wnt signaling in rheumatoid arthritis model rats via a crucial functional crosstalk between miR-152 and the DNMT1, MeCP2.在类风湿性关节炎模型大鼠中,DNA甲基转移酶1(DNMT1)通过微小RNA-152(miR-152)与DNMT1、甲基化CpG结合蛋白2(MeCP2)之间关键的功能性相互作用激活经典Wnt信号通路。
Int Immunopharmacol. 2015 Sep;28(1):344-53. doi: 10.1016/j.intimp.2015.06.013. Epub 2015 Jun 18.
3
长链非编码 RNA LINC00240 通过调节 miR-338-5p/METTL3 轴促进胃癌进展。
Bioengineered. 2021 Dec;12(2):9678-9691. doi: 10.1080/21655979.2021.1983276.
4
Molecular interactions of miR-338 during tumor progression and metastasis.miR-338 在肿瘤进展和转移过程中的分子相互作用。
Cell Mol Biol Lett. 2021 Apr 7;26(1):13. doi: 10.1186/s11658-021-00257-w.
5
A genome-wide analysis reveals the MeCP2-dependent regulation of genes in BGC-823 cells.全基因组分析揭示了BGC-823细胞中MeCP2依赖的基因调控。
Int J Clin Exp Pathol. 2020 Jul 1;13(7):1578-1589. eCollection 2020.
6
LINC00994 promoted invasion and proliferation of gastric cancer cell via regulating miR-765-3p.LINC00994通过调控miR-765-3p促进胃癌细胞的侵袭和增殖。
Am J Transl Res. 2019 Oct 15;11(10):6641-6649. eCollection 2019.
7
Analysis of microarray data for identification of key microRNA signatures in glioblastoma multiforme.分析微阵列数据以鉴定多形性胶质母细胞瘤中的关键微小RNA特征
Oncol Lett. 2019 Aug;18(2):1938-1948. doi: 10.3892/ol.2019.10521. Epub 2019 Jun 24.
8
DNA methylation contributes to silencing the expression of linc00086 in gastric cancer.DNA甲基化有助于沉默胃癌中linc00086的表达。
Oncol Lett. 2018 Aug;16(2):1931-1936. doi: 10.3892/ol.2018.8868. Epub 2018 Jun 1.
9
Peptide SA12 inhibits proliferation of breast cancer cell lines MCF-7 and MDA-MB-231 through G0/G1 phase cell cycle arrest.肽SA12通过使细胞周期停滞在G0/G1期来抑制乳腺癌细胞系MCF-7和MDA-MB-231的增殖。
Onco Targets Ther. 2018 Apr 30;11:2409-2417. doi: 10.2147/OTT.S154337. eCollection 2018.
10
miR-19a/b and MeCP2 repress reciprocally to regulate multidrug resistance in gastric cancer cells.miR-19a/b 和 MeCP2 相互抑制调节胃癌多药耐药。
Int J Mol Med. 2018 Jul;42(1):228-236. doi: 10.3892/ijmm.2018.3581. Epub 2018 Mar 22.
MicroRNA-218 inhibits bladder cancer cell proliferation, migration, and invasion by targeting BMI-1.
微小RNA-218通过靶向BMI-1抑制膀胱癌细胞的增殖、迁移和侵袭。
Tumour Biol. 2015 Sep;36(10):8015-23. doi: 10.1007/s13277-015-3532-x. Epub 2015 May 14.
4
MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signaling.微小RNA-338-3p通过靶向锌指E盒结合蛋白2以及甲硫氨酸腺苷基转移酶1A/间充质上皮转化因子/蛋白激酶B信号通路抑制胃癌细胞的上皮-间质转化
Oncotarget. 2015 Jun 20;6(17):15222-34. doi: 10.18632/oncotarget.3835.
5
miR-145 mediates the antiproliferative and gene regulatory effects of vitamin D3 by directly targeting E2F3 in gastric cancer cells.微小RNA-145通过直接靶向胃癌细胞中的E2F3来介导维生素D3的抗增殖和基因调控作用。
Oncotarget. 2015 Apr 10;6(10):7675-85. doi: 10.18632/oncotarget.3048.
6
Role of mecp2 in experience-dependent epigenetic programming.MECP2 在经验依赖型表观遗传编程中的作用。
Genes (Basel). 2015 Mar 6;6(1):60-86. doi: 10.3390/genes6010060.
7
The apoptosis associated tyrosine kinase gene is frequently hypermethylated in human cancer and is regulated by epigenetic mechanisms.凋亡相关酪氨酸激酶基因在人类癌症中经常发生高甲基化,并受表观遗传机制调控。
Genes Cancer. 2014 Sep;5(9-10):365-74. doi: 10.18632/genesandcancer.28.
8
Methylation of miR-129-5p CpG island modulates multi-drug resistance in gastric cancer by targeting ABC transporters.miR-129-5p CpG岛的甲基化通过靶向ABC转运蛋白调节胃癌中的多药耐药性。
Oncotarget. 2014 Nov 30;5(22):11552-63. doi: 10.18632/oncotarget.2594.
9
Epigenetic silencing of methyl-CpG-binding protein 2 gene affects proliferation, invasion, migration, and apoptosis of human osteosarcoma cells.甲基CpG结合蛋白2基因的表观遗传沉默影响人骨肉瘤细胞的增殖、侵袭、迁移和凋亡。
Tumour Biol. 2014 Dec;35(12):11819-27. doi: 10.1007/s13277-014-2336-8. Epub 2014 Sep 17.
10
MiR-338 suppresses the growth and metastasis of OSCC cells by targeting NRP1.微小RNA-338通过靶向神经毡蛋白1抑制口腔鳞状细胞癌细胞的生长和转移。
Mol Cell Biochem. 2015 Jan;398(1-2):115-22. doi: 10.1007/s11010-014-2211-3. Epub 2014 Sep 10.